Press Release:

With the controversy that is being reported in the UK, regarding the recent article by Dr. Wakefield, Dr. O’Leary, et al. in Molecular Pathology regarding measles in the gut, there is a new article by Dr.  Vijendra Singh, Ph.D. of Utah State University. This important ground-breaking research is below.

Raymond Gallup, president

Autism Autoimmunity Project

45 Iroquois Avenue

Lake Hiawatha, NJ 07034

Tel 973 299-9162

http://www.gti.net/truegrit/

http://www.casiquest.org/

 

Vijendra Singh, Ph.D.

singhvk@biology.usu.edu

Tel# 435 797-7193

 

Press spokesman for Dr. Wakefield and Dr. O’Leary

Abel Hadden

ahadden@ahadden.com

http://www.visceral.org.uk/

 

The latest press on the MMR vaccine and autism can be found on

http://www.jabs.org.uk/pages/mmr/main.asp

Abnormal Measles Serology and Autoimmunity in Autistic Children

Abstract 702

Vijendra K Singh

Courtney Nelson

Utah State University,

Logan, UT

[Not yet available online.]

Immune factors such as autoimmunity may play a causal role in autism.

We recently showed that many autistic children have autoantibodies to brain myelin basic protein (MBP) as well as elevated levels of measles virus antibodies. To extend this research further, we conducted a serological study of measles virus (MV), mumps virus (MuV), rubella virus (RV), cytomegalovirus (CMV), human herpesvirus-6 (HHV-6), measles-mumps-rubella (MMR), diptheria-pertussis-tetanus (DPT), diptheria-tetanus (DT) and hepatitis B (Hep B) and studied correlations with MBP autoantibodies.

Antibodies were assayed in sera of autistic children (n=125) and normal children (n=92) by ELISA or immunoblotting methods. We found that autistic children have significantly (p=0.001) higher than normal levels of MV and MMR antibodies whereas the antibody levels of MuV, RV, CMV, HHV-6, DPT, DT or Hep B did not significantly differ between autistic and normal children.

Immunoblotting analysis showed the presence of an unusual MMR antibody in 60% (75 of 125) of autistic children, but none of the 92 normal children had this antibody. Moreover, by using MMR blots and monoclonal antibodies, we found that the specific increase of MV antibodies or MMR antibodies was related to measles hemagglutinin antigen (MV-HA), but not to mumps or rubella viral proteins, of the MMR vaccine. In addition, over 90% of MMR antibody-positive autistic sera were also positive for MBP autoantibodies, suggesting a causal association between MMR and brain autoimmunity in autism.

Stemming from this evidence, we suggest that an “atypical” measles infection in the absence of a rash but with neurological symptoms might be etiologically linked to autoimmunity in autism. (Supported by grants from the James Dougherty Jr Foundation, Unanue Foundation, Lettner Jr Foundation, Autism Autoimmunity Project and Autism Research Institute)

Journal of Allergy Clin Immunol 109 (1):S232, 2002   (January).